Medical University of South Carolina

According to SRTR data from November 2025, Medical University of South Carolina reports a 1-year graft survival rate of 95.1% for lung transplants, compared to a national average of 89.6%. The 3-year survival rate is 73.9%. Survival rates are risk-adjusted estimates for a historical cohort, not a forecast for a named patient.

Medical University of South Carolina reported 50 lung transplants in the current SRTR Program-Specific Report cohort. That count is inventory from the joined program row, not a quality grade.

SRTR reports approximately 5 candidates on this program's lung waiting list in the November 2025 cohort, with about 19 waitlist additions recorded in the same report window. Stock (inventory) and additions (flow) are different SRTR fields; this page does not estimate an individual's wait.

SRTR records about 19 lung waitlist additions for Medical University of South Carolina in the November 2025 Program-Specific Report window (organ-class mean among ranked programs: 54). Additions are cohort flow, not a predicted wait time or a recommendation.

Medical University of South Carolina ranks #5 of 64 reporting lung programs by 1-year graft survival in this cohort. The center's rate is 5.5 percentage points above the national risk-adjusted benchmark. Rankings exclude programs below SRTR's published case-volume floor.

This page reports the program's SRTR 1-year and 3-year graft survival estimates, transplants performed, waitlist stock, waitlist additions (flow), and the risk-adjusted national benchmark for lung. Rank order is among programs that meet SRTR's published case-volume floor. None of those fields is a recommendation to choose or avoid the center.